)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
CG Oncology
CG Oncology (CGON) investor relations material
CG Oncology Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary9 Jun, 2026
Key value drivers and upcoming catalysts
Focused on developing cretostimogene for intermediate and high-risk non-muscle invasive bladder cancer, with pivotal PIVOT-006 phase III trial results expected soon and potential first approval in NMIBC anticipated shortly after.
Additional data on product durability in BCG unresponsive and combination settings expected later this year.
Market landscape and unmet need
NMIBC represents 80% of bladder cancer cases, with 70% of those in intermediate or high-risk categories targeted.
Unmet needs include preventing radical cystectomy in high-risk and reducing recurrent TURBTs in intermediate-risk patients.
Clinical profile and differentiation
Cretostimogene shows a 76% CR rate in CIS cohort, with 46% at 12 months and 42% at 24 months, outperforming competitors like KEYTRUDA and nadofaragene firadenovec at two years.
Consistent response rates observed even in heavily pretreated patients, including those who failed prior chemo.
Compare Creto's 24-month CR rate to competitors
Explain PIVOT-006 control arm RFS assumptions
Detail BLA filing CMC and inspection strategy
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CG Oncology
- Cretostimogene shows durable efficacy and safety in NMIBC, with pivotal data and launch prep ongoing.CGON
Jefferies Global Healthcare Conference 20263 Jun 2026 - Cretostimogene advances toward broad NMIBC use with strong data, scalable manufacturing, and launch prep.CGONRBC Capital Markets Global Healthcare Conference 202620 May 2026
- Janus IPO and portfolio strategy drive Healthpeak’s growth and value creation across healthcare real estate.CGONBank of America Global Healthcare Conference 202612 May 2026
- Net loss rose to $60.2M with $1.1B cash, supporting clinical milestones through 2029.CGONQ1 20268 May 2026
- Shareholders will vote on directors, auditor, executive pay, and annual say-on-pay frequency.CGONProxy filing24 Apr 2026
- Virtual annual meeting to elect directors, ratify auditor, and approve executive pay.CGONProxy filing24 Apr 2026
- Credo shows high efficacy and durability, with regulatory and commercial plans advancing.CGONTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Cretostimogene delivers leading efficacy and safety in NMIBC, advancing toward market launch.CGONInvestor presentation27 Feb 2026
- 2025 net loss widened to $161M as R&D ramped up, with $903M cash to fund operations into 2029.CGONQ4 202527 Feb 2026
Next CG Oncology earnings date
Q2 20267 Aug, 2026
CG Oncology
Next CG Oncology earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage